Dow Today: Johnson & Johnson (JNJ) Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading down 40.0 points (-0.2%) at 17,028 as of Monday, Jul 7, 2014, 1:36 p.m. ET. During this time, 131 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 320.4 million. The NYSE advances/declines ratio sits at 917 issues advancing vs. 2,148 declining with 110 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ), which is sporting a $1.14 gain (+1.1%) bringing the stock to $106.56. Volume for Johnson & Johnson currently sits at 3.7 million shares traded vs. an average daily trading volume of 6.6 million shares.

Johnson & Johnson has a market cap of $298.24 billion and is part of the health care sector and drugs industry. Shares are up 15.1% year-to-date as of Thursday's close. The stock's dividend yield sits at 2.7%.

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Airlines Rebuke Trump Policy of Separating Children

Airlines Rebuke Trump Policy of Separating Children

Dow Fluctuates, Nasdaq Strikes Record High

Dow Fluctuates, Nasdaq Strikes Record High

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Deutsche Bank Fined $205 Million Over Currency-Trading Violations

Deutsche Bank Fined $205 Million Over Currency-Trading Violations

Instagram Launches New Longform Video Platform

Instagram Launches New Longform Video Platform